In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT. Read more about In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer. Read more about Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer.
Advancing molecular imaging from the laboratory to everyday practice. Read more about Advancing molecular imaging from the laboratory to everyday practice.
Session 2: strategies for fast-track technological development and regulatory issues. Read more about Session 2: strategies for fast-track technological development and regulatory issues.
Current and potential applications of clinical 13C MR spectroscopy. Read more about Current and potential applications of clinical 13C MR spectroscopy.
Very low probability interpretation of V/Q lung scans in combination with low probability objective clinical assessment reliably excludes pulmonary embolism: data from PIOPED II. Read more about Very low probability interpretation of V/Q lung scans in combination with low probability objective clinical assessment reliably excludes pulmonary embolism: data from PIOPED II.
Molecular imaging update: advances in MI of the brain. Read more about Molecular imaging update: advances in MI of the brain.
Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. Read more about Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data.
Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. Read more about Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
